Cargando…
CD200R1 promotes interleukin-17 production by group 3 innate lymphoid cells by enhancing signal transducer and activator of transcription 3 activation
Psoriasis is a common chronic inflammatory skin disease with no cure. It is driven by the interleukin (IL)-23/IL-17A axis and type 17 T helper cells; however, recently, group 3 innate lymphoid cells (ILC3s) have also been implicated. Despite being the focus of much research, factors regulating the a...
Autores principales: | Linley, Holly, Ogden, Alice, Jaigirdar, Shafqat, Buckingham, Lucy, Cox, Joshua, Priestley, Megan, Saunders, Amy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270648/ https://www.ncbi.nlm.nih.gov/pubmed/36623588 http://dx.doi.org/10.1016/j.mucimm.2023.01.001 |
Ejemplares similares
-
Reduced cutaneous CD200:CD200R1 signaling in psoriasis enhances neutrophil recruitment to skin
por: Linley, Holly, et al.
Publicado: (2022) -
Interleukin‐33 increases type 2 innate lymphoid cell count and their activation in eosinophilic asthma
por: Sun, Fengfei, et al.
Publicado: (2023) -
Innate lymphoid cells type 3 in cancer
por: Castillo-González, Raquel, et al.
Publicado: (2022) -
Innate Lymphoid Cells and T Cells Contribute to the Interleukin‐17A Signature Detected in the Synovial Fluid of Patients With Juvenile Idiopathic Arthritis
por: Rosser, Elizabeth C., et al.
Publicado: (2019) -
CD1d‐mediated activation of group 3 innate lymphoid cells drives IL‐22 production
por: Saez de Guinoa, Julia, et al.
Publicado: (2016)